Helius Medical

$15.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-2.02%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Helius Medical and other stocks, options, and ETFs commission-free!

About HSDT

Helius Medical Technologies, Inc. Class A Common Stock (DE), also called Helius Medical, is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA. The listed name for HSDT is Helius Medical Technologies, Inc. Class A Common Stock (DE).

CEO
Dane Carl Andreeff
Employees
19
Headquarters
Newtown, Pennsylvania
Founded
2014
Market Cap
25.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
56.52K
High Today
$16.38
Low Today
$15.89
Open Price
$16.35
Volume
19.04K
52 Week High
$51.45
52 Week Low
$8.72

Collections

HSDT Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

VBLT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure